- Home
- AUPH vs SRCE Comparison
AUPH vs SRCE Comparison
Compare AUPH & SRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- SRCE
- Stock Information
- Founded
- AUPH 1993
- SRCE 1863
- Country
- AUPH Canada
- SRCE United States
- Employees
- AUPH N/A
- SRCE N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- SRCE Major Banks
- Sector
- AUPH Health Care
- SRCE Finance
- Exchange
- AUPH Nasdaq
- SRCE Nasdaq
- Market Cap
- AUPH 1.6B
- SRCE 1.5B
- IPO Year
- AUPH 1999
- SRCE N/A
- Fundamental
- Price
- AUPH $13.17
- SRCE $59.92
- Analyst Decision
- AUPH Strong Buy
- SRCE Hold
- Analyst Count
- AUPH 2
- SRCE 4
- Target Price
- AUPH $13.00
- SRCE $71.25
- AVG Volume (30 Days)
- AUPH 1.3M
- SRCE 80.6K
- Earning Date
- AUPH 11-04-2025
- SRCE 10-23-2025
- Dividend Yield
- AUPH N/A
- SRCE 2.54%
- EPS Growth
- AUPH N/A
- SRCE 14.53
- EPS
- AUPH 0.42
- SRCE 6.01
- Revenue
- AUPH $260,111,000.00
- SRCE $405,363,000.00
- Revenue This Year
- AUPH $17.33
- SRCE $17.85
- Revenue Next Year
- AUPH $14.31
- SRCE $1.85
- P/E Ratio
- AUPH $31.33
- SRCE $9.97
- Revenue Growth
- AUPH 25.59
- SRCE 9.59
- 52 Week Low
- AUPH $6.55
- SRCE $52.14
- 52 Week High
- AUPH $13.54
- SRCE $68.13
- Technical
- Relative Strength Index (RSI)
- AUPH 65.73
- SRCE 48.80
- Support Level
- AUPH $11.96
- SRCE $58.65
- Resistance Level
- AUPH $12.70
- SRCE $61.55
- Average True Range (ATR)
- AUPH 0.47
- SRCE 1.51
- MACD
- AUPH 0.17
- SRCE 0.15
- Stochastic Oscillator
- AUPH 85.96
- SRCE 61.34
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SRCE 1st Source Corporation
1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.